intravenous infusion (IV) of Adebrelimab (ADE)
B2024-588-01
Phase 2 small_molecule active
Quick answer
intravenous infusion (IV) of Adebrelimab (ADE) for Advanced Hepatocellular Carcinoma (HCC) is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Advanced Hepatocellular Carcinoma (HCC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active